🍽️ Manjistha (Rubia cordifolia)

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of Manjistha (Rubia cordifolia) On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Increases

Bacteria Impacted by Manjistha (Rubia cordifolia)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Terrabacteria group clade Decreases 👪 Source Study
Bacteroidota/Chlorobiota group clade Increases 👪 Source Study
Bacilli class Decreases 👶 Source Study
Clostridia class Decreases 👶 Source Study
Desulfuribacillia class Decreases 👶 Source Study
Dethiobacteria class Decreases 👶 Source Study
Erysipelotrichia class Decreases 👶 Source Study
Limnochordia class Decreases 👶 Source Study
Negativicutes class Decreases 👶 Source Study
Thermolithobacteria class Decreases 👶 Source Study
Tissierellia class Decreases 👶 Source Study
Bacteroidia class Increases 👶 Source Study
Chitinophagia class Increases 👶 Source Study
Cytophagia class Increases 👶 Source Study
Flavobacteriia class Increases 👶 Source Study
Saprospiria class Increases 👶 Source Study
Sphingobacteriia class Increases 👶 Source Study
Bacteroidia class Increases 📓 Source Study
Rikenellaceae family Decreases 📓 Source Study
Rikenellaceae family Decreases 👪 Source Study
Alistipes genus Decreases 📓 Source Study
Acetobacteroides genus Decreases 👶 Source Study
Alistipes genus Decreases 👶 Source Study
Anaerocella genus Decreases 👶 Source Study
Millionella genus Decreases 👶 Source Study
Mucinivorans genus Decreases 👶 Source Study
Rikenella genus Decreases 👶 Source Study
Tidjanibacter genus Decreases 👶 Source Study
Akkermansia genus Increases 👪 Source Study
Bacillota sensu stricto incertae sedis no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
unclassified Alistipes no rank Decreases 👶 Source Study
unclassified Bacillota no rank Decreases 👶 Source Study
Bacteroidetes incertae sedis no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Bacteroidota no rank Increases 👶 Source Study
Bacteroidales order Decreases 👪 Source Study
Bacteroidales order Increases 👶 Source Study
Marinilabiliales order Increases 👶 Source Study
unclassified Bacteroidetes Order II. order Increases 👶 Source Study
Bacillota phylum Decreases 📓 Source Study
Bacteroidota phylum Increases 👪 Source Study Over 70%ile, prone to being fat
Bacteroidota phylum Increases 📓 Source Study Over 70%ile, prone to being fat
Alistipes communis species Decreases 👶 Source Study
Alistipes dispar species Decreases 👶 Source Study
Alistipes finegoldii species Decreases 👶 Source Study
Alistipes ihumii species Decreases 👶 Source Study
Alistipes indistinctus species Decreases 👶 Source Study
Alistipes inops species Decreases 👶 Source Study
Alistipes massiliensis species Decreases 👶 Source Study
Alistipes megaguti species Decreases 👶 Source Study
Alistipes obesi species Decreases 👶 Source Study
Alistipes onderdonkii species Decreases 👶 Source Study
Alistipes provencensis species Decreases 👶 Source Study
Alistipes putredinis species Decreases 👶 Source Study
Alistipes senegalensis species Decreases 👶 Source Study
Alistipes shahii species Decreases 👶 Source Study
Alistipes timonensis species Decreases 👶 Source Study
Akkermansia muciniphila species Increases 📓 Source Study
Akkermansia muciniphila ATCC BAA-835 strain Increases 👶 Source Study
Chlamydiae/Verrucomicrobia group superphylum Increases ⚗️ Source Study

Impact of Manjistha (Rubia cordifolia) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.5 1.1 -1.2
ADHD 0.7 0.7 0
Allergic Rhinitis (Hay Fever) 0 0
Allergies 0.8 1.3 -0.63
Allergy to milk products 0.8 -0.8
Alopecia (Hair Loss) 0.5 0.5
Alzheimer's disease 1.2 1.8 -0.5
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.6 2.3 -2.83
Ankylosing spondylitis 0.5 0.8 -0.6
Anorexia Nervosa 0.5 0.2 1.5
Asthma 0.9 0.5 0.8
Atherosclerosis 1.1 0.2 4.5
Atrial fibrillation 0.3 0.3 0
Autism 2.1 2.6 -0.24
Bipolar Disorder 0.8 1.3 -0.63
Brain Trauma 0 0
Carcinoma 0.3 0.3 0
Celiac Disease 1.1 0.8 0.38
Cerebral Palsy 0.3 -0.3
Chronic Fatigue Syndrome 0.4 1.3 -2.25
Chronic Kidney Disease 0.9 -0.9
Chronic Urticaria (Hives) 1.4 1.4
Coagulation / Micro clot triggering bacteria 0.2 0.2
Colorectal Cancer 1 0.8 0.25
COVID-19 2.7 2.8 -0.04
Crohn's Disease 1.3 1.3 0
Depression 3 1.7 0.76
Dermatomyositis 1.3 -1.3
Eczema 0 0.8 0
Endometriosis 0.5 0.5
Eosinophilic Esophagitis 1.5 -1.5
Epilepsy 2.6 0.8 2.25
Fibromyalgia 0.5 0.5
Functional constipation / chronic idiopathic constipation 0.8 1.5 -0.88
gallstone disease (gsd) 0.3 -0.3
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.7 0.4 0.75
Generalized anxiety disorder 0 0
giant cell arteritis 0 0
Gout 0.4 0.8 -1
Graves' disease 0.2 1.9 -8.5
Hashimoto's thyroiditis 0.3 0.3 0
Heart Failure 0.2 0.2
Hidradenitis Suppurativa 0.5 -0.5
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.3 0.3
hypercholesterolemia (High Cholesterol) 0.6 0.6
hyperglycemia 0.9 0.9
Hyperlipidemia (High Blood Fats) 0.8 0.8 0
hypertension (High Blood Pressure 1.3 0.6 1.17
Hypoxia 0.3 -0.3
IgA nephropathy (IgAN) 0.5 -0.5
Inflammatory Bowel Disease 1.9 1 0.9
Insomnia 0.5 -0.5
Irritable Bowel Syndrome 1.1 1.4 -0.27
Juvenile idiopathic arthritis 0.9 -0.9
Liver Cirrhosis 0.6 0.6 0
Long COVID 1 2.7 -1.7
Low bone mineral density 0.3 -0.3
Lung Cancer 0.6 0.3 1
ME/CFS with IBS 0.3 0.3
Metabolic Syndrome 2.7 1.7 0.59
Mood Disorders 3.1 3.1 0
multiple chemical sensitivity [MCS] 0.3 -0.3
Multiple Sclerosis 1.5 1.4 0.07
Multiple system atrophy (MSA) 0.2 0.9 -3.5
Neuropathy (all types) 1.3 1.1 0.18
neuropsychiatric disorders (PANDAS, PANS) 0.4 0.9 -1.25
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1.2 0.4 2
Obesity 2.7 1.5 0.8
obsessive-compulsive disorder 0.9 0.9
Osteoarthritis 0.2 0.5 -1.5
Osteoporosis 1 2.1 -1.1
Parkinson's Disease 0.7 1.8 -1.57
Polycystic ovary syndrome 0.3 0.7 -1.33
Premenstrual dysphoric disorder 0.8 0.8
Psoriasis 2.3 0.6 2.83
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.1 -1.1
Rosacea 1.3 -1.3
Schizophrenia 0.2 2.3 -10.5
sensorineural hearing loss 0.4 0.4
Sjögren syndrome 0.8 0.3 1.67
Sleep Apnea 0.5 0.7 -0.4
Small Intestinal Bacterial Overgrowth (SIBO) 0.5 -0.5
Stress / posttraumatic stress disorder 0.6 0.8 -0.33
Systemic Lupus Erythematosus 1 1 0
Tourette syndrome 0.3 -0.3
Type 1 Diabetes 0.9 0.4 1.25
Type 2 Diabetes 2.6 1.7 0.53
Ulcerative colitis 2.4 1.3 0.85
Unhealthy Ageing 0.3 0.3

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)